PR86157 Sole Source Justification_Redacted.pdf

This document is a Sole Source Justification for a procurement opportunity. The Centers for Disease Control and Prevention (CDC) intends to award a sole source firm fixed price purchase order to Quest Diagnostics for de-identified remnant nasopharyngeal specimens. Quest Diagnostics possesses a repository of residual specimens from diagnostic testing across the US public health jurisdiction, which can be used for pertussis pathogen genomic surveillance. Comparable products are not available from other commercial sources in a timely manner, and existing surveillance networks fail to recover sufficient representative specimens. The CDC will leverage an existing legal partnership to receive proprietary specimens from Quest Diagnostics. Interested parties may identify their interest and capability to respond to the requirement or submit proposals by 4:00PM EST on May 3, 2024, though this is not a request for competitive quotations.